Prosecution Insights
Prosecution Insights
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PHILIPOSE, HANNAH SARAH | 1 | 0.0% | +0.0% |
| MOORE, JOHN DAVID | 1 | 70.5% | +18.1% |
| BRAUN, MADELINE E | 1 | 68.0% | +24.9% |
| THUESON, HANNA MARIE | 1 | 71.4% | +30.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18376566 | METHOD FOR PREPARING MESENCHYMAL STEM CELL-DERIVED EXTRACELLULAR VESICLE, MESENCHYMAL STEM CELL-DERIVED EXTRACELLULAR VESICLE PREPARED BY THE METHOD, AND USE OF MESENCHYMAL STEM CELL-DERIVED EXTRACELLULAR VESICLE FOR REDUCING ADIPOGENESIS AND TREATING OSTEOARTHRITIS | PHILIPOSE, HANNAH SARAH | 19d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18126273 | METHOD FOR TREATING DEMYELINATING CONDITIONS | BRAUN, MADELINE E | 157d overdue |
| 18066999 | METHOD FOR STABLY AMPLIFYING PLURIPOTENT STEM CELL | THUESON, HANNA MARIE | 49d overdue |
| 18376459 | METHOD FOR PREPARING COMPOSITION COMPRISING MESENCHYMAL STEM CELL, EXTRACELLULAR VESICLE PRODUCED BY MESENCHYMAL STEM CELL, AND GROWTH FACTOR, COMPOSITION PREPARED BY THE METHOD, AND USE OF COMPOSITION FOR TREATING ARTHRITIS | MOORE, JOHN DAVID | 33d |
| Art Unit | Apps |
|---|---|
| 1638 | 2 |
| 1631 | 1 |
| 1624 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18376566 | METHOD FOR PREPARING MESENCHYMAL STEM CELL-DERIVED EXTRACELLULAR VESICLE, MESENCHYMAL STEM CELL-DERIVED EXTRACELLULAR VESICLE PREPARED BY THE METHOD, AND USE OF MESENCHYMAL STEM CELL-DERIVED EXTRACELLULAR VESICLE FOR REDUCING ADIPOGENESIS AND TREATING OSTEOARTHRITIS | PHILIPOSE, HANNAH SARAH | 1631 | §103 | Non-Final OA | 19d | Pending | Oct 04, 2023 |
| 18376459 | METHOD FOR PREPARING COMPOSITION COMPRISING MESENCHYMAL STEM CELL, EXTRACELLULAR VESICLE PRODUCED BY MESENCHYMAL STEM CELL, AND GROWTH FACTOR, COMPOSITION PREPARED BY THE METHOD, AND USE OF COMPOSITION FOR TREATING ARTHRITIS | MOORE, JOHN DAVID | 1638 | §103 | Final Rejection | 33d | Pending | Oct 04, 2023 |
| 18126273 | METHOD FOR TREATING DEMYELINATING CONDITIONS | BRAUN, MADELINE E | 1624 | §103 | Final Rejection | 157d overdue | Pending | Mar 24, 2023 |
| 18066999 | METHOD FOR STABLY AMPLIFYING PLURIPOTENT STEM CELL | THUESON, HANNA MARIE | 1638 | §103 | Final Rejection | 49d overdue | Pending | Dec 15, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial